Clinical trials
Clinical clinical trials
Below are recruiting clinical clinical trials, each written for real people, not researchers. We’re tracking 5,435 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06556667Recruiting
Comparing two cardioversion methods for persistent AFib
This trial compares two ways of doing cardioversion (a procedure to restore normal heart rhythm) for people with persistent atrial fibrillation. It aims to see if one approach leads to a better recovery and fewer complications.
Ottawa, OntarioAges 18 years+ - NCT06430814Recruiting
Blood test to predict nerve damage from paclitaxel
This study looks at whether certain markers in your blood can predict nerve damage from paclitaxel chemotherapy. If you join, researchers will monitor your nerve health during treatment to better understand and possibly prevent side effects.
OdenseAges 18 years+ - NCT06194838Recruiting
Mechanical vs. powered knee for above-knee amputees
This study compares a non-powered (mechanical) knee to a powered (battery-assisted) knee for people with above-knee amputations who walk at a moderate level (K2). It will help find out which knee type works better for your daily activities and mobility.
Austin, TexasAges 18 years+ - NCT06309251Recruiting
Ketogenic diet for children with epilepsy or other conditions
This trial studies how well a ketogenic diet works for children with hard-to-treat epilepsy or certain other diseases. It aims to see if the diet improves quality of life.
Milan, MIAges Up to 18 years - NCT06546345Recruiting
Study of KeriFlex® implant for hand joint replacement
This trial tracks how well the KeriFlex® implant works over time in people who need a finger joint replacement due to arthritis or injury. It aims to see if the implant helps reduce pain and improve hand function.
BesançonAges 18 years+ - NCT06548607RecruitingEarly Phase 1
CAR-T therapy for autoimmune diseases
This early-phase trial tests a new CAR-T cell therapy that targets CD19 or both CD19 and BCMA to treat several autoimmune diseases like lupus, scleroderma, and vasculitis. It aims to calm the overactive immune system with a single infusion of your own engineered cells.
Bengbu, AnhuiAges 18–70 - NCT06534723RecruitingPhase 3
Wujia Yizhi granules for mild-to-moderate Alzheimer's
This trial tests if a Chinese herbal granule (Wujia Yizhi) can help people with mild-to-moderate Alzheimer's dementia. It is for patients who have memory problems for at least 6 months and meet specific Alzheimer's biomarker criteria.
Fuzhou, FujianAges 50–80 - NCT06549348Recruiting
Aortic repair study using less radiation
This study tests a new way to guide a complex aortic surgery (fenestrated endovascular repair) using less or no radiation. It may help people with aneurysms who need repair involving the arteries that supply the liver, gut and kidneys.
Birmingham, AlabamaAges 18 years+ - NCT06538064Recruiting
Study of HyQvia for Adults with CIDP in Routine Care
This study looks at how well HyQvia works for adults with CIDP in everyday medical practice. It includes people who are already using HyQvia or are switching to it.
Rancho Mirage, CaliforniaAges 18 years+ - NCT06538376Recruiting
New portable chest X-ray for ICU patients
This study tests a new portable chest X-ray that can be used in the ICU to check for problems like fluid in the lungs, trouble breathing, or swallowing issues. It is designed to help doctors see these problems more easily without moving you to the radiology department.
Boston, MassachusettsAges 18 years+ - NCT06536452Recruiting
How blood cell production differs in CLL, MBL, and healthy people
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
Rochester, MinnesotaAges 40 years+ - NCT06541210Recruiting
Prostate health study for Black men in Jacksonville
This study from Mayo Clinic aims to improve prostate health and reduce cancer disparities in Black men by building community partnerships in Jacksonville, Florida. It involves community leaders, health workers, and Black adults sharing their experiences and insights.
Jacksonville, FloridaAges 21–80 - NCT06533371Recruiting
Ultrasound for emphysema in COPD and lung cancer
This study uses ultrasound (a safe, painless sound wave test) to check for emphysema (damaged air sacs in the lungs) in people with COPD or those being screened for lung cancer. It aims to see if ultrasound can replace the need for CT scans.
Acquaviva delle FontiAges 18 years+ - NCT06533813Recruiting
Studying health outcomes in people with myelofibrosis
This study collects information from people diagnosed with myelofibrosis to understand how the disease affects them over time. It may help researchers learn more about the condition and improve future care.
YerevanAges 18–100 - NCT06535113Recruiting
Inflammation and treatment response in AML
This study looks at how inflammation (the body's response to injury or infection) affects treatment outcomes in people with acute myeloid leukemia (AML). If you have a new diagnosis or have stored samples from a past diagnosis, you may help researchers understand why some people respond better to therapy.
Reggio Calabria, CalabriaAges 18 years+ - NCT06532474Recruiting
Muscle function study in SMA patients on SMN therapies
This study looks at how muscles work in children and young adults with spinal muscular atrophy (SMA) who are taking or starting SMN-directed therapies (like Evrysdi, Spinraza, or Zolgensma). It aims to understand the body's response to these treatments, which could help improve future care.
Memphis, TennesseeAges 5–20 - NCT06540326RecruitingPhase 2
Second-line therapy for advanced colorectal cancer
This trial tests a combination of chemotherapy with either bevacizumab or cetuximab as a second-line treatment for advanced colorectal cancer. It aims to find which option works better for patients whose first treatment failed.
Hangzhou, ZhejiangAges 18–75 - NCT06548204RecruitingPhase 2
Antihistamine after a heart attack
This trial tests whether taking an antihistamine medicine called fexofenadine hydrochloride can help people recover better after a heart attack. It is a randomized study, so some participants will receive the medicine and others will receive a placebo (a pill with no active ingredients).
Hangzhou, ZhejiangAges 18 years+ - NCT06533436Recruiting
Comparing two ways to secure a breathing tube
This study compares two methods of holding a breathing tube in place for patients who are already intubated. The goal is to see which method works better and costs less.
SuresnesAges 18 years+ - NCT03978039Recruiting
Sarcoma patient registry for people treated in France
This trial builds a national database of people diagnosed with sarcoma in French cancer centers. It may help researchers better understand sarcoma types and care patterns, which can improve future treatment decisions.
BordeauxAges Any age - NCT05543447Recruiting
Safety and effectiveness of a brain blood-vessel device for aneurysms
This study tests how safe and effective the DERIVO 2heal device is for treating an intracranial (brain) aneurysm. You may be a candidate if you’re an adult with an aneurysm that doctors plan to treat with this specific device and you can safely take anti-platelet medicines.
AugsburgAges 18 years+ - NCT06525532Recruiting
Tracking reabsorbable implant for flatfoot in kids
This study tracks how well a special reabsorbable implant works over time in children and teens who had subtalar surgery for flatfoot. You'll have an MRI to see how the implant has changed and if it helped your foot.
BolognaAges 8–15 - NCT06526507Enrolling by invitationPhase 4
PrEP study for pregnant women in Kenya
This study aims to expand access to PrEP (a daily pill that prevents HIV) for pregnant and postpartum women visiting maternal and child health clinics in Kenya. It also includes health care workers who provide PrEP services.
Kapsabet, NandiAges 15–50 - NCT06521671Recruiting
Fracture healing after hip surgery in younger adults
This trial tests whether a new surgical method helps hip fractures heal better in adults aged 18 to 64. It uses special X-rays to track how the bone moves over time.
AarhusAges 18–65
Hear when a new Clinical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for clinical?
- Yes. Clin2 currently lists 5,435 recruiting clinical studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a clinical trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a clinical trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.